CDK3/CCNC(CDK3/cyclin C)
Sign in to save this workspaceUniProt CDK3: Q00526; cyclin C: P24863 · PDB · AlphaFold (Q00526), AlphaFold (P24863) · Substrate: CHKtide · Clone: full length / full length
Top inhibitors
| # | Drug | Inhibition | Residual | KISS | Gini |
|---|---|---|---|---|---|
| 1 | Rabusertib | 80.3% | 19.7% | 98.74 | 0.687 |
| 2 | Repotrectinib | 73.4% | 26.6% | 84.21 | 0.608 |
| 3 | Pacritinib | 70.5% | 29.5% | 88.64 | 0.452 |
| 4 | Ceritinib | 60.0% | 40.0% | 95.44 | 0.618 |
| 5 | Upadacitinib | 59.0% | 41.0% | 97.98 | 0.663 |
| 6 | Fedratinib | 52.6% | 47.4% | 96.21 | 0.576 |
| 7 | Defactinib | 50.1% | 49.9% | 92.68 | 0.450 |
| 8 | Darovasertib | 40.4% | 59.6% | 96.99 | 0.719 |
| 9 | Paxalisib | 26.6% | 73.4% | 99.75 | 0.609 |
| 10 | Selpercatinib | 22.5% | 77.5% | 96.72 | 0.635 |
| 11 | Mobocertinib | 20.4% | 79.6% | 97.22 | 0.757 |
| 12 | Entrectinib | 20.2% | 79.8% | 93.69 | 0.671 |
| 13 | Crizotinib | 19.8% | 80.2% | 91.39 | 0.581 |
| 14 | Ponatinib | 19.3% | 80.7% | 78.23 | 0.534 |
| 15 | Abrocitinib | 17.4% | 82.6% | 99.50 | 0.581 |
| 16 | Pemigatinib | 15.0% | 85.0% | 98.23 | 0.718 |
| 17 | Neratinib | 14.4% | 85.6% | 93.18 | 0.597 |
| 18 | Capivasertib | 14.1% | 85.9% | 96.48 | 0.644 |
| 19 | Avapritinib | 13.4% | 86.6% | 97.73 | 0.644 |
| 20 | Deucravacitinib | 12.7% | 87.3% | 98.99 | 0.718 |
Paralog block
No paralog group registered for this kinase.
EMT expression
Not in the EMT expression panel.
Selectivity landscape vs inhibition on CDK3/CCNC
Each point is one of the 92 approved drugs; color = inhibition % on CDK3/CCNC.
3D structure
Embedded NGL viewer pulls a representative PDB entry (or AlphaFold model if no experimental structure is registered). Heavy bundle — loaded only on demand.
Annotations
Sign in to read and post annotations.
Loading…